Lumipulse® G β-Amyloid 1-40

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human cerebrospinal fluid (CSF).  

The Lumipulse G β-Amyloid 1-40 assay is intended to be used in conjunction with Lumipulse G β-Amyloid 1-42 assay to determine the amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) in the clinical setting of dementia diagnosis.  

This CSF amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

The CSF amyloid ratio supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.

CE marked
Lumipulse® G β-Amyloid 1-40 Immunoreaction Cartridges

Product number 231524

3 x 14 Tests
Lumipulse® G β-Amyloid 1-40 Calibrators

Product number 231531

2 x 3 Concentrations
Please contact your local Fujirebio representative for the availability of this product in your country.
Lumipulse G β-Amyloid 1-40 Immunoreaction Cartridges (231524) and Lumipulse G β-Amyloid 1-40 Calibrators (231531) Lumipulse G CLIA analyzer cartridge close up LUMIPULSE G1200 fully automated CLEIA analyzer with sample kit package LUMIPULSE G1200 fully automated CLEIA analyzer - cartridge loading

Click here to navigate

  • Contact sales for information
  • Details
  • Conditions of sale
  • Documentation
  • Insights
  • Related products
  • Product inquiry

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.